← Back to news
S

Seeking Alpha: News

Targa Resources reports Q1 results

S

Vir Biotechnology anticipates VIR-5500 Phase III start in 2027 while expecting cash runway into 2H 2028

S

Haemonetics Non-GAAP EPS of $1.29 beats by $0.02, revenue of $346M beats by $9.14M

S

SwissCom reports Q1 results

S

Celsius Non-GAAP EPS of $0.41 beats by $0.12, revenue of $782.6M beats by $21.97M

S

Crane NXT declares $0.18 dividend

B

Miller declares $0.21 dividend

B

Kyowa Kirin reports Q1 results

B

Revolution Medicines outlines $1.7B-$1.8B in 2026 GAAP operating expenses while expanding RASolve 301 to 590 patients

B

Barrett Business declares $0.08 dividend

B

RATIONAL Aktiengesellschaft reports Q1 results

B

Canadian Natural Resources declares CAD 0.625 dividend

B

Solvay reports Q1 results

S

White House aims for July 4 passage of Clarity Act, crypto adviser says

S

Six Flags CFO to step down

S

KORU targets $47.5M-$50M 2026 revenue while planning next-gen Freedom60 510(k) and MDR submissions

S

LegalZoom raises 2026 revenue outlook to $810M-$830M while targeting $190M-$200M adjusted EBITDA

S

Fastly stock tumbles despite earnings beat, raised guidance

S

Six Flags reports Q1 results

S

Canadian Natural Resources Non-GAAP EPS of C$1.17; reaffirms FY outlook

S

Euro Area retail sales rise 1.2% Y/Y

S

Sight Sciences signals $83M-$89M 2026 revenue outlook while targeting $6M-$8M dry eye sales

S

Vanda targets $240M-$290M 2026 revenue as it introduces $10M-$30M NEREUS sales outlook

S

Anthropic’s finance AI agents promise gains, but adoption hurdles persist

S

Stock index futures muted as traders await potential U.S.-Iran peace deal updates

S

Castle Biosciences targets $345M-$355M 2026 revenue as TissueCypher volumes grow 58% and AdvanceAD-Tx reaches ~650 orders

S

Acadia reaffirms 2026 total revenue guidance of $1.22B-$1.28B as remlifanserin Phase II ADP readout nears

S

ACV outlines 2026 revenue of $845M-$855M while authorizing $100M buyback amid mid-single-digit dealer wholesale decline outlook

S

Accuray withdraws guidance amid Middle East disruptions while targeting $25M annualized profitability improvement in fiscal 2027

S

Amplitude forecasts $397M-$403M FY2026 revenue as it adds $16M incremental ARR from Statsig partnership

S

Henkel AG & Co. reports Q1 results

S

Gold Fields reports Q1 results; reaffirms FY26 outlook

B

Europe equities mostly higher amid hopes of U.S.-Iran peace deal

B

SK Telecom reports Q1 results

B

Rheinmetall Q1 surges on defense demand, reaffirms guidance

B

Australia logs first trade deficit in over 8 years, export dip and import spike

B

SpaceX IPO said to hand Elon Musk unchecked power; investor group urges SEC scrutiny

B

Oil in red as market awaits Iran response; Trump sees swift end to war

B

Avolta AG reports Q1 results

S

Hamilton Beach reiterates 2026 outlook with $35M-$45M cash flow target as it plans reinvestment amid consumer softness

S

Mineralys outlines lorundrostat U.S. launch plans ahead of December 22, 2026 PDUFA

S

Alto outlines $15M in 2026 45Z net proceeds while targeting ~8% Pekin dry mill capacity lift by Q4

S

Ruger expects $30M in 2026 capex as Beretta agreement avoids proxy contest

S

ams-OSRAM AG reports Q1 results

S

U.S.-Iran truce odds surge as markets anticipate de-escalation

S

Park-Ohio beats top-line estimates; reaffirms FY26 outlook

S

Acushnet Holdings Corp. declares $0.255 dividend

S

RGC Resources GAAP EPS of $0.84 beats by $0.06, revenue of $45.46M beats by $7.26M

S

Kraft Heinz launches $1.1B tender offer for 2046 and 2049 senior notes

S

TScan Therapeutics GAAP EPS of -$0.22 misses by $0.01, revenue of $1M misses by $1.5M

S